Results 171 to 180 of about 90,058 (326)

Cognitive and behavioural predictors of survival in Alzheimer disease:results from a sample of treated patients in a tertiary-referral memory clinic [PDF]

open access: yes, 2012
Agüero-Torres   +59 more
core   +1 more source

Humility and Medicine, Lessons Learned: Perhaps the Fifth Ethics Principle

open access: yes
Journal of the American Geriatrics Society, EarlyView.
Michael Gordon
wiley   +1 more source

Impact of hippocampal α‐synuclein oligomers on cognitive trajectory in patients with dementia with Lewy bodies

open access: yesAlzheimer's &Dementia, Volume 21, Issue 8, August 2025.
Abstract INTRODUCTION Increasing evidence indicates that α‐synuclein (αSYN) oligomers are toxic. We sought to determine whether αSYN oligomers were associated with faster cognitive decline in prospectively‐followed patients with dementia with Lewy bodies (DLB).
Hiroaki Sekiya   +8 more
wiley   +1 more source

Integrating neuroinflammation biomarkers into the ATN(X) framework: Advances in Alzheimer's pathogenesis, diagnosis, and insights from non‐human primate models

open access: yesAlzheimer's &Dementia, Volume 21, Issue 8, August 2025.
Abstract The amyloid/tau/neurodegeneration (ATN) biomarker framework has greatly progressed the diagnosis and staging of Alzheimer's disease (AD). However, recent research highlights neuroinflammation as an equally critical factor in AD pathology across humans, rodents, and non‐human primates (NHPs).
Zhihui Jin   +3 more
wiley   +1 more source

Patterns and predictors of cholinesterase inhibitor use in dementia with Lewy bodies. [PDF]

open access: yesAlzheimers Dement (N Y)
Heo RJ   +7 more
europepmc   +1 more source

Modernizing diagnosis of Alzheimer's disease: A review of global trends and Asia‐specific perspectives

open access: yesAlzheimer's &Dementia, Volume 21, Issue 8, August 2025.
Abstract The landscape of Alzheimer's disease (AD) and related dementias (ADRD) diagnosis is evolving rapidly, driven by advances in disease understanding, biomarker tools, and disease‐modifying therapies. Modern diagnostic approaches emphasize biological precision, early detection, and dynamic frameworks that adapt to treatment‐induced changes in ...
Takeshi Iwatsubo   +43 more
wiley   +1 more source

Home - About - Disclaimer - Privacy